SCHEMBL7987224

SCHEMBL7987224

O=c1nc(-c2ccccc2)[nH]c2ncn(Cc3ccccc3F)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
PDE4A P27815 5/20 0.43
PDE4B Q07343 5/20 0.43
PDE4C Q08493 5/20 0.43
PDE4D Q08499 5/20 0.43
ALDH1A1 P00352 1/20 0.42
PARN O95453 1/20 0.40
CNOT7 Q9UIV1 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TP53 P04637 2/20 0.39
ROCK2 O75116 1/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
PKLR P30613 1/20 0.39
PDE5A O76074 3/20 0.39
PDE1A P54750 3/20 0.39
PDE1B Q01064 3/20 0.39
PDE1C Q14123 3/20 0.39
PDE3B Q13370 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986760 0.93 ALDH1A1 (0.41) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL7991418 0.92 ALDH1A1 (0.40) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL7988753 0.90 ACP1 (0.41) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL7985415 0.89 ALDH1A1 (0.39) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL7985119 0.89 CNOT7 (0.42) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL7974203 0.88 ACP1 (0.41) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL7984682 0.88 PDE4A (0.39) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL7973921 0.88 ALDH1A1 (0.42) LMNAPDE4APDE4BPDE4CPDE4D
SCHEMBL7984791 0.86 SMN1; SMN2 (0.45) LMNAALDH1A1PARNCNOT7MEN1
SCHEMBL7974083 0.86 ACP1 (0.43) LMNAALDH1A1PARNCNOT7MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed